Skip to main content
Log in

Hemofiltration for hyperbilirubinemia after left ventricular assist system implantation: Report of four cases

  • Case Reports
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

We hypothesized that the use of hemofiltration (HF) to reduce cytokines may attenuate the hyperbilirubinemia that often develops after left ventricular assist system (LVAS) implantation. Four patients with hyperbilirubinemia after LVAS implantation underwent HF continuously for 7 days. Blood samples were collected and the serum concentrations of total bilirubin (T-Bil), interleukin (IL)-6, and IL-8 were measured. We also measured the serum concentrations of IL-6 and IL-8 in the blood flowing into and out of the filter. Two patients had reduced serum concentrations of IL-6, IL-8, and T-Bil, but the other two did not, despite the effective filtration of these cytokines. Our findings suggest that the reduction of cytokines by HF may assist in the treatment of hyperbilirubinemia after LVAS placement in some patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675–681.

    Article  PubMed  CAS  Google Scholar 

  2. Kormos RL, Murali S, Dew MA, Armitage JM, Hardesty RL, Borovetz HS, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994;57:51–57.

    PubMed  CAS  Google Scholar 

  3. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. HeartMate LVAS Investigators. Left ventricular assist system. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. JTCS 2001;122:1186–1195.

    CAS  Google Scholar 

  4. Yamaguchi T, Sawa Y, Masai T, Nishimura M, Chang JC, Nishida T, et al. Hepatic sinusoid endothelial dysfunction plays a role in hyperbilirubinemia in patients following implantation of an LVAD. ASAIO J 1997;43:M449–M452.

    PubMed  CAS  Google Scholar 

  5. Thomas K, Sonja EV, Gerald PP. Cytokine patterns who undergo hemofiltration for treatment of multiple organ failure. World J. Surg 1998;22:443–448.

    Article  Google Scholar 

  6. Nakae H, Motoyama S, Kurosawa S, Inaba H. The effective removal of proinflammatory cytokines by continuous hemofiltration with a polymethylmethacrylate membrane following severe burn injury: report of three cases. Surg Today 1999;29:762–765.

    Article  PubMed  CAS  Google Scholar 

  7. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522–526.

    Article  PubMed  CAS  Google Scholar 

  8. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673–679.

    Article  PubMed  CAS  Google Scholar 

  9. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829–1835.

    Article  PubMed  CAS  Google Scholar 

  10. Hummel M, Czerlinski S, Friedel N, Liebenthal C, Hasper D, von Baehr R, et al. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Crit Care Med 1994;22:448–454.

    Article  PubMed  CAS  Google Scholar 

  11. Finkel MS, Hoffman RA, Shen L, Oddis CV, Simmons RL, Hattler BG. Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am J Cardiol 1993;71:1231–1232.

    Article  PubMed  CAS  Google Scholar 

  12. Heidemann SM, Ofenstein JP, Sarnaik AP. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 1994;44:183–187.

    PubMed  CAS  Google Scholar 

  13. Freeman BD, Yatsiv I, Natanson C, Solomon MA, Quezado ZM, Danner RL, et al. Continuous arteriovenous hemofiltration dose not improve survival in canine model of septic shock. J Am Coll Surg 1995;180:286–292.

    PubMed  CAS  Google Scholar 

  14. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 1995;21:169–176.

    Article  PubMed  CAS  Google Scholar 

  15. Schouten WE, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nube MJ. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 2000;15:379–384.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyagawa, S., Nishimura, M., Fukushima, N. et al. Hemofiltration for hyperbilirubinemia after left ventricular assist system implantation: Report of four cases. Surg Today 38, 747–750 (2008). https://doi.org/10.1007/s00595-007-3731-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-007-3731-1

Key words

Navigation